0001181431-14-010850.txt : 20140305
0001181431-14-010850.hdr.sgml : 20140305
20140305061305
ACCESSION NUMBER: 0001181431-14-010850
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140303
FILED AS OF DATE: 20140305
DATE AS OF CHANGE: 20140305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001386858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611512713
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-745-7802
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Management VII, L.L.C.
CENTRAL INDEX KEY: 0001421501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 14667353
BUSINESS ADDRESS:
STREET 1: 2800 SAND HILL ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-681-8420
MAIL ADDRESS:
STREET 1: 2800 SAND HILL ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOFINNOVA VENTURE PARTNERS VII L P
CENTRAL INDEX KEY: 0001380734
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 14667354
BUSINESS ADDRESS:
STREET 1: 2800 SAND HILL ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-681-8420
MAIL ADDRESS:
STREET 1: 2800 SAND HILL ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buatois Eric
CENTRAL INDEX KEY: 0001362314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 14667355
MAIL ADDRESS:
STREET 1: 2800 SAND HILL ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POWELL MICHAEL
CENTRAL INDEX KEY: 0001202793
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 14667356
MAIL ADDRESS:
STREET 1: 2800 SAND HILL ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEALY JAMES
CENTRAL INDEX KEY: 0001245624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 14667357
MAIL ADDRESS:
STREET 1: 2800 SAND HILL ROAD
STREET 2: SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
rrd404420.xml
DISTRIBUTION
X0306
4
2014-03-03
0
0001386858
HYPERION THERAPEUTICS INC
HPTX
0001245624
HEALY JAMES
C/O SOFINNOVA VENTURES
2800 SAND HILL ROAD, SUITE 150
MENLO PARK
CA
94025
1
0
1
0
0001202793
POWELL MICHAEL
C/O SOFINNOVA VENTURES
2800 SAND HILL ROAD, SUITE 150
MENLO PARK
CA
94025
0
0
1
0
0001362314
Buatois Eric
C/O SOFINNOVA VENTURES
2800 SAND HILL ROAD, SUITE 150
MENLO PARK
CA
94025
0
0
1
0
0001380734
SOFINNOVA VENTURE PARTNERS VII L P
C/O SOFINNOVA VENTURES
2800 SAND HILL ROAD, SUITE 150
MENLO PARK
CA
94025
0
0
1
0
0001421501
Sofinnova Management VII, L.L.C.
C/O SOFINNOVA VENTURES
2800 SAND HILL ROAD, SUITE 150
MENLO PARK
CA
94025
0
0
1
0
Common Stock
2014-03-03
4
J
0
590000
0
D
2357221
I
See footnote
Common Stock
2014-03-03
4
J
0
23625
0
A
23625
I
See footnote
Common Stock
2014-03-04
4
S
0
23625
30.02
D
0
I
See footnote
Common Stock
11855
D
Shares disposed of by way of distribution to the partners of Sofinnova Venture Partners VII, L.P. ("SV VII") pro rata and without consideration, in accordance with its partnership agreement and a Rule 10b5-1 Distribution Plan adopted by it on December 13, 2013, as amended (the "Distribution").
The shares are owned directly by SV VII. Sofinnova Management VII, L.L.C. ("SV VII LLC"), the general partner of SV VII, and James Healy, a director of the Issuer, Michael Powell, and Eric Buatois, the managing members of SV VII LLC, may be deemed to have shared voting and dispositive power over the shares owned by SV VII. Such persons and entities disclaim beneficial ownership over the shares owned by SV VII except to the extent of any pecuniary interest therein.
Shares acquired by SV VII LLC in connection with the Distribution of such shares to the partners of SV VII.
The shares are owned directly by SV VII LLC. James Healy, a director of the Issuer, Michael Powell, and Eric Buatois, the managing members of SV VII LLC, may be deemed to have shared voting and dispositive power over the shares owned by SV VII LLC. Such persons and entities disclaim beneficial ownership over the shares owned by SV VII LLC except to the extent of any pecuniary interest therein.
Shares disposed of in accordance with a Rule 10b5-1 Sales Plan adopted by SV VII LLC on December 16, 2013, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.70 to $30.50, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.
The common stock was issued on March 8, 2012 upon the early exercise of an option that was immediately exercisable in full upon grant. One quarter of the shares vested on April 15, 2012, and the remainder of the shares vest at a rate of 1/36th per month thereafter. All exercised but unvested shares are subject to a repurchase right by the Issuer.
The shares are owned directly by Mr. Healy.
/s/ Nathalie Auber, Attorney-in-Fact for James Healy
2014-03-04
/s/ Nathalie Auber, Attorney-in-Fact for Eric Buatois
2014-03-04
/s/ Nathalie Auber, Attorney-in-Fact for Michael Powell
2014-03-04
/s/ Nathalie Auber, Attorney-in-Fact for Sofinnova Venture Partners VII, L.P.
2014-03-04
/s/ Nathalie Auber, Attorney-in-Fact for Sofinnova Management VII, L.L.C.
2014-03-04